Differentiation HHD From HCM (EARLY-MYO-HHD)
EARLY Differentiation of MYOcardial Hypertrophy Between Hypertensive Heart Disease and Hypertrophic Cardiomyopathy
Sponsor: Beijing Anzhen Hospital
Listed as NCT03271385, this observational or N/A phase trial focuses on Hypertensive Heart Disease and Hypertrophic Cardiomyopathy and remains completed. Sponsored by Beijing Anzhen Hospital, it has been updated 9 times since 2017, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
-
Apr 2022 — Dec 2022 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Apr 2020 — Jan 2021 [monthly]
Recruiting
-
Jun 2018 — Apr 2020 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Beijing Anzhen Hospital
- Kunming Medical University
- LanZhou University
- RenJi Hospital
- Ruijin Hospital
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- West China Hospital
For direct contact, visit the study record on ClinicalTrials.gov .